http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2411911-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fae7a54eac5192cf5c4caca9bdcf2b08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00 |
| filingDate | 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc2644699fd188123188c01c5c08be8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a46ae72c6488fc97a4f0bc4b21a87701 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55397c7023d75f33f985dbddf41ccc44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bed75aff8630e7ac0320e102036740fb |
| publicationDate | 2011-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2411911-C1 |
| titleOfInvention | Method of predicting character of reperfusion syndrome course after phased surgical treatment of frontal artery in patients with symptomatic bicarotid stenoses |
| abstract | FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, in particular, to vascular surgery. Phased surgical treatment of frontal arteries in patients with symptomatic bicarotid stenoses, including at the first stage reconstruction of one internal frontal artery, at the second stage - another internal frontal artery, is carried out. In order to predict character of reperfusion syndrome course, carried out are clinical-instrumental examination and determination in blood serum of level of primary, secondary and final isopropanol-soluble (ISPP, ISSP, ISFP), heptane-soluble (GSPP, GSSP, GSFP) products of lipid peroxidation and ascorbate-induced lipid peroxidation (AOA-1, AOA-2) as well as level of biologically active substances - serotonin, nitrites, nitrates in time periods before the second stage of aversion carotid endarterectomy, as well as on 1-3, 4-7 and 8-14 day after its performance. Using values of ISPP, ISSP, ISFP, GSPP, GSSP, GSFP, AOA-1, AOA-2, serotonin, nitrites and nitrates levels with respect to norm in said periods of time, favourable or unfavourable reperfusion syndrome course is predicted. ^ EFFECT: method increases reliability of reperfusion syndrome prediction after phased surgical treatment of frontal arteries in patients with symptomatic bicarotid stenoses. ^ 4 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2684363-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2697604-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2566437-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2711414-C1 |
| priorityDate | 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.